Induction of immunity against experimental tuberculosis with mycobacterial mannophosphoinositides encapsulated in liposomes containing lipid A.
Mycobacterial mannophosphoinositides (PIMs) encapsulated in liposomes made of egg phosphatidylcholine (EPC) and cholesterol (CH) (2:1.5 molar ratio) were able to induce humoral and delayed type hypersensitivity (DTH, foot-pad swelling reaction) responses in mice without the help of any carrier protein. Animals immunized with this glycophospholipid antigen demonstrated enhanced percent survival on intravenous challenge with virulent M. tuberculosis. On fractionation of PIMs, pentamannophosphoinositide (PIM5) was found to induce higher antibody and DTH reaction and proved to be more immunoprotective than other fractions. Inclusion of lipid A as immunomodulator in liposomes containing PIMs or PIM5 resulted in a significantly increased immune response. Further, mice immunized with PIMs or PIM5 in lipid A-containing liposomes exhibited decreased mortality on challenge with M. tuberculosis H37Rv, which was comparable to BCG vaccinated animals.
Singh
A P
AP
Department of Biochemistry, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Khuller
G K
GK
D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000818:Animals; D005260:Female; D007114:Immunization; D008050:Lipid A / Q000627:therapeutic use; D008081:Liposomes / Q000627:therapeutic use; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009169:Mycobacterium tuberculosis / Q000737:chemistry* / Q000276:immunology*; D010716:Phosphatidylinositols / Q000276:immunology / Q000627:therapeutic use*; D014376:Tuberculosis / Q000517:prevention & control*
D000276:Adjuvants, Immunologic; D008050:Lipid A; D008081:Liposomes; D010716:Phosphatidylinositols; C002423:mannophosphoinositide